$ads={1}
About HOOKIPA:
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA’s replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ cell responses and pathogen-neutralizing antibodies. HOOKIPA’s pipeline includes its wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.
About HOOKIPA:
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA’s replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ cell responses and pathogen-neutralizing antibodies. HOOKIPA’s pipeline includes its wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.
Position Summary:
We are looking for an enthusiastic and committed (senior) scientist to lead a translational research team aiming to characterize the immunological response to arenavirus immunotherapy in human in vitro models and clinical trial samples.
Main Responsibilities:
- Lead translational research projects with a team of 3 experienced lab technicians.
- Develop scientific strategy for translational research projects, in close consultation with the head of department and relevant stakeholders (Clinical Biomarkers, Global R&D…)
- Design and perform experiments focused on antigen specific CD8+ T cell characterization in primary human cells (e.g. ELISpot, FACS, gene expression analyzes, TCR sequencing…)
- Analyze and interpret data, troubleshoot as required.
- Implement these techniques for exploratory analyses of clinical trial samples, according to GCP guidelines.
- Write, review and approve SOPs, study plans and reports.
- Oversee technical and theoretical training of team members.
- Evaluate deviations, review, approve and release data.
- Present and discuss results at internal and external meetings.
- Manage team´s resources and timelines, coordinating the work of team members and external partners and prioritizing projects and tasks as needed.
- Maintain engagement of team members and promote their personal development.
- Contribute to a friendly and productive work environment, consistently thriving for improvement.
Qualifications & Skills:
- PhD in life sciences
- Minimum 3 years hands-on laboratory experience with immunological assays and primary human cell culture techniques
- Experience with working under GCP guidelines for clinical trial sample analysis is an advantage.
- Independent and proactive work style, detail-oriented, well-organized
- Strong interpersonal skills, open-minded and flexible team-player
- Able to motivate others and lead by example
- Excellent written and oral communication skills in English
What we offer:
- Strong team with dedicated and passionate employees
- State of the art infrastructure
- An excellent working atmosphere
- Opportunities for personal development
- Employee benefits such as health screening, public transportation card, Sodexo pass
- Working in a multinational and multicultural environment
We are required by Austrian law to post a minimum salary. The minimum monthly gross salary for this position is EUR 4.112,- based on fulltime (40 hours per week); depending on experience and qualification salary can be negotiated. In addition, we offer a performance-related bonus payment and participation in our stock option compensation program. The position is a temporary replacement (Karenzvertretung) and is expected to last until 30.06.2025.
Starting date: as soon as possible
Contact:
If you (m/f/d) are interested in this challenging position, please send your CV including a cover letter (summarizing your qualification and experiences) together with your credentials.
For more information on HOOKIPA please visit www.hookipapharma.com
Contact:
Contact:
If you (m/f) are interested in this challenging position, please send your CV including a cover letter summarizing your qualification and experiences to: talent@hookipabiotech.com
For more information on HOOKIPA please visit www.hookipabiotech.com
